Annual Short Term Debt
$562.60 K
-$166.50 K-22.84%
31 December 2022
Summary:
Navidea Biopharmaceuticals annual short term debt is currently $562.60 thousand, with the most recent change of -$166.50 thousand (-22.84%) on 31 December 2022. During the last 3 years, it has fallen by -$477.80 thousand (-45.92%). NAVB annual short term debt is now -98.92% below its all-time high of $51.96 million, reached on 31 December 2016.NAVB Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$1.26 M
-$78.60 K-5.87%
30 September 2023
Summary:
Navidea Biopharmaceuticals quarterly short term debt is currently $1.26 million, with the most recent change of -$78.60 thousand (-5.87%) on 30 September 2023. NAVB quarterly short term debt is now -97.58% below its all-time high of $51.96 million, reached on 31 December 2016.NAVB Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -45.9% | +258.3% |
| 5 y5 years | +28.8% | +404.6% |
NAVB Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.9% | at low | -5.9% | +4513.6% |
| 5 y | 5 years | -45.9% | +28.8% | -5.9% | +4513.6% |
| alltime | all time | -98.9% | -97.6% |
Navidea Biopharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $1.26 M(-5.9%) |
| June 2023 | - | $1.34 M(+278.6%) |
| Mar 2023 | - | $353.40 K(-37.2%) |
| Dec 2022 | $562.60 K(-22.8%) | $562.60 K(+1960.8%) |
| Sept 2022 | - | $27.30 K(-76.9%) |
| June 2022 | - | $118.40 K(-62.1%) |
| Mar 2022 | - | $312.10 K(-57.2%) |
| Dec 2021 | $729.10 K(-29.9%) | $729.10 K(+107.4%) |
| Sept 2021 | - | $351.50 K(+12.0%) |
| June 2021 | - | $313.90 K(-36.6%) |
| Mar 2021 | - | $494.80 K(-52.4%) |
| Dec 2020 | $1.04 M(+87.0%) | $1.04 M(+59.6%) |
| Sept 2020 | - | $651.90 K(-5.2%) |
| June 2020 | - | $687.60 K(+54.9%) |
| Mar 2020 | - | $443.90 K(-20.2%) |
| Dec 2019 | $556.50 K(+27.4%) | $556.50 K(+123.0%) |
| Sept 2019 | - | $249.60 K(-24.6%) |
| June 2019 | - | $331.00 K(-24.9%) |
| Mar 2019 | - | $440.80 K(+0.9%) |
| Dec 2018 | $436.80 K(-82.3%) | $436.80 K(-80.9%) |
| Sept 2018 | - | $2.28 M(-2.5%) |
| June 2018 | - | $2.34 M(-2.0%) |
| Mar 2018 | - | $2.39 M(-3.0%) |
| Dec 2017 | $2.46 M(-95.3%) | $2.46 M(+24.2%) |
| Sept 2017 | - | $1.98 M(-0.8%) |
| June 2017 | - | $2.00 M(-5.0%) |
| Mar 2017 | - | $2.10 M(-96.0%) |
| Dec 2016 | $51.96 M(>+9900.0%) | $51.96 M(+0.6%) |
| Sept 2016 | - | $51.65 M(0.0%) |
| June 2016 | - | $51.65 M(+2.9%) |
| Mar 2016 | - | $50.18 M(>+9900.0%) |
| Dec 2015 | $333.30 K(-92.3%) | $333.30 K(0.0%) |
| Sept 2015 | - | $333.30 K(0.0%) |
| June 2015 | - | $333.30 K(-94.5%) |
| Mar 2015 | - | $6.09 M(+40.1%) |
| Dec 2014 | $4.35 M(+6.2%) | $4.35 M(+59.6%) |
| Sept 2014 | - | $2.73 M(+248.3%) |
| June 2014 | - | $782.50 K(>+9900.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $4.10 M(+48.6%) | $4.10 M(+142.0%) |
| Sept 2013 | - | $1.69 M(+1994.2%) |
| June 2013 | - | $80.80 K(-97.1%) |
| Mar 2013 | - | $2.77 M(+0.4%) |
| Dec 2012 | $2.76 M(>+9900.0%) | $2.76 M(+13.6%) |
| Sept 2012 | - | $2.43 M(+3.6%) |
| June 2012 | - | $2.34 M(+40.9%) |
| Mar 2012 | - | $1.66 M(>+9900.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(-100.0%) |
| June 2011 | - | $9100.00(-74.7%) |
| Mar 2011 | - | $36.00 K(-42.3%) |
| Dec 2010 | $62.40 K(>+9900.0%) | $62.40 K(+505.8%) |
| Sept 2010 | - | $10.30 K(-14.2%) |
| June 2010 | - | $12.00 K(+3.4%) |
| Mar 2010 | - | $11.60 K(>+9900.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2009 | - | $7100.00(-83.1%) |
| June 2009 | - | $42.00 K(-55.5%) |
| Mar 2009 | - | $94.30 K(-35.8%) |
| Dec 2008 | $146.90 K | $146.90 K(+1104.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2008 | - | $12.20 K(-65.1%) |
| June 2008 | - | $35.00 K(-58.6%) |
| Mar 2008 | - | $84.60 K(-39.3%) |
| Dec 2007 | $139.40 K(-92.5%) | $139.40 K(-96.5%) |
| Sept 2007 | - | $4.04 M(+54.9%) |
| June 2007 | - | $2.61 M(-10.3%) |
| Mar 2007 | - | $2.91 M(+57.3%) |
| Dec 2006 | $1.85 M(+741.6%) | $1.85 M(>+9900.0%) |
| Sept 2006 | - | $16.40 K(-80.6%) |
| June 2006 | - | $84.50 K(-44.3%) |
| Mar 2006 | - | $151.70 K(-30.9%) |
| Dec 2005 | $219.60 K(-14.4%) | $219.60 K(+513.4%) |
| Sept 2005 | - | $35.80 K(-66.0%) |
| June 2005 | - | $105.40 K(-42.4%) |
| Mar 2005 | - | $183.00 K(-28.7%) |
| Dec 2004 | $256.60 K(+27.0%) | $256.60 K(+58.4%) |
| Sept 2004 | - | $162.00 K(+0.3%) |
| June 2004 | - | $161.50 K(+26.7%) |
| Mar 2004 | - | $127.50 K(-36.9%) |
| Dec 2003 | $202.00 K(+8.0%) | $202.00 K(-53.3%) |
| Sept 2003 | - | $432.20 K(-0.6%) |
| June 2003 | - | $434.90 K(+301.9%) |
| Mar 2003 | - | $108.20 K(-42.2%) |
| Dec 2002 | $187.10 K(+7.0%) | $187.10 K(-90.7%) |
| Sept 2002 | - | $2.01 M(+93.4%) |
| June 2002 | - | $1.04 M(+858.3%) |
| Mar 2002 | - | $108.70 K(-37.8%) |
| Dec 2001 | $174.80 K(+49.8%) | $174.80 K(+1298.4%) |
| Sept 2001 | - | $12.50 K(-54.4%) |
| June 2001 | - | $27.40 K(-62.2%) |
| Mar 2001 | - | $72.50 K(-37.9%) |
| Dec 2000 | $116.70 K(-96.4%) | $116.70 K(+960.9%) |
| Sept 2000 | - | $11.00 K(-94.4%) |
| June 2000 | - | $196.30 K(-25.7%) |
| Mar 2000 | - | $264.20 K(-78.0%) |
| Dec 1999 | $3.22 M(+140.1%) | - |
| June 1999 | - | $1.20 M(-7.7%) |
| Mar 1999 | - | $1.30 M(-3.1%) |
| Dec 1998 | $1.34 M(+273.9%) | $1.34 M(+123.6%) |
| Sept 1998 | - | $600.00 K(0.0%) |
| June 1998 | - | $600.00 K(+100.0%) |
| Mar 1998 | - | $300.00 K(-16.4%) |
| Dec 1997 | $358.80 K(+79.4%) | $358.80 K(+258.8%) |
| Sept 1997 | - | $100.00 K(0.0%) |
| June 1997 | - | $100.00 K(0.0%) |
| Mar 1997 | - | $100.00 K(-50.0%) |
| Dec 1996 | $200.00 K(-50.0%) | $200.00 K(-71.4%) |
| Sept 1996 | - | $700.00 K(+250.0%) |
| June 1996 | - | $200.00 K(-33.3%) |
| Mar 1996 | - | $300.00 K(-25.0%) |
| Dec 1995 | $400.00 K(0.0%) | $400.00 K(+33.3%) |
| Sept 1995 | - | $300.00 K(0.0%) |
| June 1995 | - | $300.00 K(0.0%) |
| Mar 1995 | - | $300.00 K(-25.0%) |
| Dec 1994 | $400.00 K(+100.0%) | $400.00 K(+100.0%) |
| Sept 1994 | - | $200.00 K(0.0%) |
| June 1994 | - | $200.00 K(0.0%) |
| Mar 1994 | - | $200.00 K(0.0%) |
| Dec 1993 | $200.00 K(+100.0%) | $200.00 K(+100.0%) |
| Dec 1992 | $100.00 K | $100.00 K |
FAQ
- What is Navidea Biopharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual short term debt?
The current annual short term debt of NAVB is $562.60 K
What is the all time high annual short term debt for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual short term debt is $51.96 M
What is Navidea Biopharmaceuticals quarterly short term debt?
The current quarterly short term debt of NAVB is $1.26 M
What is the all time high quarterly short term debt for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly short term debt is $51.96 M